What’s stated in the protocol? [NCA / SHAM]

posted by murthynaidu – India, 2014-06-20 17:48 (3590 d 04:45 ago) – Posting: # 13107
Views: 4,686

Dear Helmut

Thanks for your immediate reply.

A full wash out was considered and in protocol it was stated about Cτ,ss is the concentration at the end of dosing interval in steady state. As the EMEA new guideline for MR product is suggesting for the evaluation of Cτ,ss as one of the primary parameter.

I have read in the forum stating that the requirements as per the new or draft guidelines shall also be addressed to avoid further queries from regulatory at the time of submission. Since there are no time point deviations in sample collection i have to check BE for concentration at 12 hr or 24 hrs on day 6.

Regards,
Murthynaidu

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,668 registered users;
44 visitors (0 registered, 44 guests [including 5 identified bots]).
Forum time: 22:33 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5